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ABSTRACT 
 
 
Is a follow up endoscopic retrograde cholangiography 
procedure necessary for removal of biliary stent? 
Shashank Ponugoti 
Follow up endoscopic retrograde cholangiopancreatography (ERCP) procedure is 
routinely performed to remove biliary stents. Simply removing the stents is 
feasible with upper endoscopy (EGD), which costs less, is technically less 
challenging, is likely to be more comfortable for the patient, and is safer from a 
sedation perspective. But therapeutic interventions requiring ERCP may 
preclude this option. The aim of this study was to analyze the utility of follow up 
ERCP for biliary stent removal and to determine if follow up ERCP procedure is 
necessary in all patients. The study population comprised 284 adults who had 
undergone ERCP for stent placement and stent removal at the WVU Endoscopy 
Center between January 2005 and December 2011. Detailed information on each 
patient was obtained from medical records. Patients were categorized into five 
groups - those with bile leak alone (N=31), choledocholithiasis (N=127), benign 
stricture (N=77), malignant stricture (N=44) and bile leak with stone or stricture 
(N=5). On follow up ERCP, only 16% of patients in the bile leak group required 
therapy. In contrast, 90% of patients with choledocholithiasis, 82% of patients 
with benign stricture and 100% of patients in the remaining two groups required 
therapy that could only be accomplished with follow up ERCP. The two most 
common employed therapies in follow up ERCPs were stone or sludge removal 
(57%) and stent replacement (35%). Conclusions: In this retrospective study 
spanning 7 years, only 16% of patients with uncomplicated bile leak required a 
follow up ERCP for stent removal, whereas ERCP related interventions were 
needed at follow-up in 82-100% of patients with other conditions. Larger 
prospective studies are needed to confirm these findings and to determine if EGD 
might serve as a viable and cost effective alternative to ERCP in cases of 
uncomplicated bile leak. 
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IS A FOLLOW UP ENDOSCOPIC RETROGRADE 
CHOLANGIOGRAPHY PROCEDURE NECESSARY 
FOR REMOVAL OF BILIARY STENT? 
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INTRODUCTION: 
 
 
Endoscopic retrograde cholangiopancreatography (ERCP) is the preferred 
procedure for purposes of diagnosis and therapy in pathological conditions of 
biliary and pancreatic origin. In particular, ERCP is generally performed to treat 
obstructive jaundice due to common bile and/or pancreatic duct obstruction. 
While ERCP has been used to treat obstructions of varying etiologies, stone 
removal   using   ERCP   is   most   commonly   performed   in   patients   with 
choledocholithiasis
1
.  Usually,  a  biliary  stent  is  deployed  after  cleaning  the 
 
common bile duct (CBD) either by evacuating stones or by dilatation of the 
stricture. The stent is placed temporarily and should be removed after a certain 
period of time with either repeat ERCP or side viewing EGD. Bile leak is a 
complication secondary to iatrogenic trauma during cholecystectomy that occurs 
in 2% of cases
2 
or blunt trauma to the abdomen. The common modality of 
treatment for bile leak is to use ERCP for placing a biliary stent to cover the 
leak
3,4
. Although the optimal length of time for stent removal is not known, the 
stent is usually removed within 3-8 weeks after ensuring the complete healing of 
the bile leak
4
. Benign and malignant strictures of the biliary tree are other frequent 
complications that require ERCP for cholangiography, dilatation, cytology 
brushings and stent placement
1
. The standard practice at our institution was to 
repeat  the  ERCP  in  6-8  weeks  following  the  initial  procedure  to  assess 
2  
 
 
 
 
 
 
 
 
improvement,  determine  potential  complications,  and  perform  any  required 
procedures, including stent removal or exchange. 
 
While ERCP is widely used and may be necessary in certain settings, there 
are also challenges associated with ERCP procedures. For example, expertise in 
ERCP requires extensive training and experience in both diagnostic and 
therapeutic ERCP procedures 
5
. The endoscopist must be prepared and competent 
to perform any indicated therapeutic intervention(s) at the time of diagnostic 
ERCP procedure
6
. ERCP procedures are associated with significantly greater 
morbidity and mortality than EGD even when performed by highly skilled 
clinicians
1,7
.  In addition, the complication rate for ERCP is higher than that of all 
other commonly performed endoscopies
8
. Complications are both procedure- and 
 
anesthesia-related 
9,10
. The cost of the ERCP is also much higher than those of 
regular endoscopy 
11,12
. 
 
Biliary stents can be removed either by ERCP or by side viewing 
EGD
13,14
. However, there have been very few studies comparing the effectiveness 
of EGD to ERCP in removal of biliary stents, and currently specific 
recommendations for use of EGD vs ERCP are lacking. Simply removing the 
stents is feasible with EGD, a procedure which is less costly, technically less 
challenging, more comfortable for the patient and safer from a sedation 
perspective than ERCP. In this retrospective chart review study, we assessed the 
3  
 
 
 
 
 
 
 
 
utility of follow up ERCP to help determine if EGD can serve as a cost effective 
alternative to ERCP for stent removal. We conducted this study to investigate the 
role of ERCP in the management of patients with biliary stents; in addition, we 
conducted an in depth evaluation to determine if follow up ERCP procedure is 
necessary for biliary stent removal and to identify the conditions for which follow 
up cholangiography may be absolutely required at the time of stent removal. 
 
 
 
 
 
METHODS: 
 
 
Potential subjects for the research study were identified from the West 
Virginia integrated data repository (IDR), a centralized electronic database that 
pools clinical information from sources throughout the state. All data are 
deidentified to protect patient confidentiality. The database was queried to obtain 
a list of all adults above eighteen years of age who had undergone ERCP for stent 
placement and stent removal (CPT codes 43268 and 43269) at the WVU 
Endoscopy Center at Ruby Memorial Hospital between January 2005 and 
December 2011. All charts were evaluated in detail and pertinent information 
gathered, including that regarding demographics, diagnosis based on imaging and 
ERCP findings, indications for the procedure, procedural findings and type of 
intervention used. Patients who underwent biliary stent placement at an outside 
facility, or pancreatic stent placement or exchange, as well as patients lost to 
4  
 
 
 
 
 
 
 
 
follow up were excluded from the analysis. This study was approved by the 
Institutional Review Board (Tracking # H-20344) at West Virginia University, 
Morgantown, WV. 
 
 
 
 
 
Data abstraction 
 
 
Medical records of the subjects were accessed by the principal 
investigator. Pertinent data on each patient were entered into a Microsoft excel 
spreadsheet using a standardized template, including information on: 
demographics, initial diagnosis, indication for the procedure, findings and 
interventions performed and date of the ERCP procedure, as well as follow-up 
ERCP findings and interventions. The time interval between the ERCP was also 
measured. Data were pooled based on the diagnosis and specific interventions 
performed. 
 
 
 
 
 
Definitions 
 
 
For each patient, age was defined as the age at the date of initial ERCP 
procedure. Diagnosis of the condition was determined based on findings from 
imaging, the initial ERCP and pathology reports. Patients were categorized into 
five   groups   based   on   the   following   presenting   diagnoses-   bile   leak, 
5  
 
 
 
 
 
 
 
 
choledocholithiasis, benign stricture, malignant stricture and bile leak with stone 
or stricture. Bile leak generally occurs as a complication of the cholecystectomy 
or in response to blunt trauma to the abdomen. Spontaneous bile leaks are very 
rare. 
 
 
 
 
 
Statistical analysis 
 
 
All data analyses were performed using statistical software R (ref). 
Descriptive statistical analyses were performed to characterize the study 
population, including mean with standard deviation (or median with range) for 
continuous variables and proportions or contingency tables for categorical 
variables. The variables of interest include patient diagnoses and complications, 
time intervals between the initial and follow-up ERCP, and procedures performed. 
A consort diagram was used to describe the schematic design of the study 
population. A bar-plot was used to display the ERCP findings among various 
diagnoses groups. Chi Square test or Fishers Exact tests were used to determine 
between group differences in categorical variables; and t-tests were used to 
investigate between-group difference in continuous variables. Statistical analyses 
were considered significant if p-value was less than 0.05. 
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Figure 1: Schematic design of the subjects included and excluded in the study 
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RESULTS: 
 
 
A total of 430 patients underwent ERCP procedure for various conditions 
during the period between 1 January 2005 and 31 December 2011. Of these 
patients, 146 did not meet our inclusion criteria, yielding a final sample of 284 
eligible adults (Figure 1). Of the 146 excluded patients, five had complicated 
initial ERCP procedure with multiple complications requiring immediate follow 
up ERCP; 37 had stent placement in an outside facility; 26 were lost to follow up; 
and 78 had pancreatic stent placement and/or exchange. 
 
Subjects were categorized into five diagnostic groups based on findings 
from initial ERCP procedure; these included Bile leak (N=31), 
Choledocholithiasis (N=127), Benign stricture (N=77), Malignant  stricture 
(N=44) and Bile leak with Stone or Stricture (N=5). Of the 5 patients in bile leak 
with stone or stricture group, four had microlithiasis (including stone/sludge), and 
one had stricture of the CBD as secondary findings. 
 
Patient demographics, overall and by group are given in Table 1. Patients 
ranged from 15 to 90 years of age with a mean age of 59 (±19) years; 41% were 
male. Age varied substantially among groups, with group means ranging from 
45.4(±19.34) years in those with simple bile leak to 66.5(±11.7) years in those 
with malignant stricture. Average age in the bile leak group was significantly 
8  
 
 
 
 
 
 
 
 
lower than that in all other groups (P<0.001). There was no significance between 
group differences in gender distribution (P’s> 0.5, Fisher exact test) (Table 1). 
 
All the patients (100%) analyzed had follow-up ERCP for stent removal. Ninety 
six percent (272/284) of the patients underwent sphincterotomy during the initial 
procedure; in contrast, only 24 patients underwent sphincterotomy during their 
follow up ERCP. Of these 24 patients, 9 did not have spinchterotomy performed 
during the initial ERCP procedure. The remaining 15 patients underwent an 
extension of sphincterotomy. 
 
The most common intervention performed during follow up ERCP was 
sludge or stone removal, followed by dilatation and brushings and stent 
placement. One patient with bile leak and stricture underwent extension 
sphincterotomy during follow up ERCP. None of the patients in the 
uncomplicated bile leak group (n=31) had sphincterotomy during follow up 
ERCP. The time interval between stent placement and removal/exchange ranged 
from 4 to 303 days, with a median time interval of 77 days. The median time 
interval was significantly lower in the malignant stricture group than in the 
remaining groups (p=<0.007; two-sample t-test). All patients with malignant 
stricture 44 (100%) required stent exchanges with metallic stent in follow up 
ERCP. 
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Table 1:  Demographics of the subjects by diagnoses group 
 
 Total (N) Male, n(%) Age range Mean age (SD) 
     
Bile Leak 31 16 (52) 18-80 45.4 (19.34) 
Stone 127 51 (40) 15-89 59.0 (20.62) 
Stricture(benign) 77 27 (35) 23-90 61.0 (17.78) 
BL/S/S 5 3 (60) 56-79 65.0 (8.98) 
Malignant Stricture 44 20 (45) 45-90 66.5 (11.68) 
Benign Pathology 240 97 (40) 15-90 57.7 (19.93) 
     
Total 284 117 (41) 15-90 59.1 (19.11) 
 
 
Table 1: Demographics: Stone – Choledocholithiasis, BL/S/S – Bile leak with Stone or stricture, 
Benign pathology (BP) = Total – Malignant stricture. SD- Standard deviation. Age group was 
significantly lower in Bile leak group compared to all other groups (p<0.001). No significant 
group differences in gender distribution (p>0.05). 
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All patients in Bile leak group with Stone or Stricture had abnormal pathology 
during follow up ERCP, requiring intervention only possible using ERCP. One 
patient had benign CBD stricture with further dilatation, brushings and stent 
exchange performed during follow up ERCP; after 64 days, a third ERCP was 
needed for stent removal after ensuring adequate patency of CBD. The remaining 
four patients had stone/sludge along with bile leak at the time of initial ERCP. 
Although the sludge/stone was extracted during initial ERCP, all four required 
intervention with sludge extraction during follow up ERCP. 
 
Of the 31 patients in Bile leak group, 26 (84%) had normal ERCP and completely 
healed bile leak, requiring no further intervention at follow-up. The remaining 
five patients had abnormal findings at follow-up ERCP, including one with 
persistent bile leak at a 34 day follow up ERCP; this patient was successfully 
treated with placement of a stent, which was removed at 6 weeks following ERCP 
confirmation of complete healing. The remaining four patients had sludge 
extracted during the second ERCP procedure, although initial ERCP procedure 
notes did not indicate stone or sludge extraction. All cases of bile leak were due to 
complications of cholecystectomy. 
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Median Time  
interval between 97 77 64 87 80 37 77 
ERCP’s – in days (27-190) (7-193) (5-252) (76-145) (5-252) (4-303) (4-303) 
(Range)        
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Findings and Interventions performed during initial and follow up ERCP 
Procedures. 
 
 
 
 
BL CDL BS BL/S/S BP MS TOTAL 
 
 
 
 
Total, N 31 127 77 5 240 44 284 
 
 
 
 
 
 
 
 
 
Normal result on 
repeat ERCP n 
(%) 
 
 
 
 
 
 
 
 
 
26(84) 13(10) 14(18) 0(0) 53(22) 0(0) 53(19) 
 
Dilatation/ 
Brushings/Balloon 
extraction 
n (%) 
 
 
4(13) 108(85) 54(70) 4(80) 170(71) 11(25) 181(64) 
 
 
Sphincterotomy 
 
 
0(0) 
 
 
12(9) 
 
 
7(9) 
 
 
1(20) 
 
 
20(8) 
 
 
4(9) 
 
 
24(8) 
n (%)        
 
Stent Placement 
1(3)
 
 
23(18) 
 
31(40) 
 
1(20) 
 
56(23) 
 
44(100) 
 
100(35) 
n (%) 
 
 
 
Table 2: Procedural therapies performed in different groups in follow up ERCP. BL – Bile leak, CDL- 
Choledocholithiasis and Microlithiasis, BS- Benign stricture, BL/S/S – Bile leak with Stone or Stricture, MS- 
Malignant stricture, BP- Benign Pathology = BL +CDL+BS+ BL/S/S, SD – Standard deviation 
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As shown in table 3, findings at follow-up ERCP were abnormal in a 
significantly lower percentage of patients with uncomplicated bile leak(16% 
(5/31)) than in those with Choledocholithiasis- (90% (114/127)) (p<0.0001), 
Benign stricture (82% (63/77)) (p<0.0001), bile leak with stone or stricture (100% 
(5/5)) (p 0.0007), or malignant stricture (100% (44/44)) (p<0.0001).  Eighty-four 
% (26/31) of the patients with uncomplicated bile leak had normal findings on 
repeat ERCP, whereas only 10% of the patients with choledocholithiasis and 18% 
with benign stricture had normal findings on repeat ERCP. Interestingly, none 
(0%) of the patients in malignant obstruction group or Bile leak with Stone or 
Stricture group had normal findings on repeat ERCP. 
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Table 3: Normal and abnormal findings of follow up ERCP by diagnoses 
group and statistical analysis. 
 
 
  
Bile Leak 
n(%) 
 
Choledocho- 
lithiasis 
n (%) 
 
Benign 
Stricture 
n (%) 
 
Bile leak + 
Stone/stricture 
n (%) 
 
Malignant 
Stricture 
n (%) 
 
Normal 
N = 53 
 
26(84) 
 
13(10) 
 
14(18) 
 
0(0) 
 
0(0) 
 
Abnormal 
N= 231 
 
5(16) 
 
114(90) 
 
63(82) 
 
5(100) 
 
44(100) 
 
p-value 
 
ref 
 
<0.0001 
 
<0.0001 
 
0.0007 
 
<0.0001 
 
 
 
 
Table 3: Statistical analysis between normal and abnormal findings, Normal: no leak 
or obstruction or strictures in follow up ERCP. Abnormal: either leak or stone or 
stricture in follow up ERCP requiring intervention. 
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Figure  2. Bar-plot  of  follow-up  ERCP  findings  among various  diagnoses 
groups. 
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DISCUSSION: 
 
 
Biliary stent placement is a common endoscopic procedure for various 
biliary pathologies by conventional ERCP. ERCP is associated with several life 
threatening complications, including those directly related to the procedure 
8,15
 
and those related to anesthesia 
10,16
. In addition, the cost of ERCP is much higher 
 
than that of regular EGD
14,17,18
. The procedure is also challenging to perform, 
requiring extensive training and experience. Given these drawbacks, we 
conducted a study using existing patient data to determine if ERCP is necessary 
for stent removal in all patient populations. We performed a retrospective chart 
review in all patients who underwent stent removal and compared findings, for 5 
patient groups, of initial and follow up ERCP. Our study results suggest that, in 
all but patients with simple bile leak, repeat ERCP is likely necessary as a follow 
up procedure for stent removal as most will require therapy along with stent 
removal, which can be accomplished only with ERCP. However, in patients with 
uncomplicated bile leak, use of a regular side viewing EGD would likely be 
sufficient to remove the stent in the vast majority of cases. 
 
Complications of ERCP include pancreatitis, hemorrhage, cholangitis, 
septicemia 
19
, perforation and various other complications such as recurrent stone 
formation and sphincterotomy stenosis
8,20,21
. Pancreatitis occurs in 6.7% of 
general population and in up to 15–30% of high-risk patients22. Bleeding is seen 
16  
 
 
 
 
 
 
 
endoscopically in 10-30% of the patients undergoing Sphincterotomy
23
. 
Perforation is reported in less than 1% of the patients undergoing ERCP and 
sphincterotomy
24-26
. 
 
Previous findings regarding need for ERCP during stent removal in 
patients with bile leak have been inconsistent, rendering the establishment of 
specific recommendations for use of ERCP vs EGD challenging. For example, 
Coelho and Baron showed good results for stent removal with EGD in their recent 
study of 64 post bile leak patients
14
. In contrast, Jain et al showed significant 
abnormalities requiring ERCP for stent removal in their investigation of 80 bile 
leak patients
13
. This inconsistency in findings may in part reflect differences in 
patient populations. However, to our knowledge, no previous studies have 
investigated potential variation in outcome and associated need for ERCP at stent 
removal in different patient diagnostic groups. 
 
Several studies have reported costs of ERCP procedures to substantially 
exceed those of regular endoscopy procedure
12,17,18
. Likewise, we found similar 
cost discrepancies in our analysis of ERCP and EGD billing data from the WVU 
Endoscopy center using Medicare/Medicaid reimbursement rates. Costs for ERCP 
with stent removal using Code 43269 are $2163.76 vs. $977.13 for an EGD with 
stent removal/intervention (coded as 43267), a difference of $1186.63 per 
procedure. These figures are consistent with the findings of Coelho et al., who 
17  
 
 
 
 
 
 
 
 
showed that approximately $500,000 a year can be saved using EGD rather than 
ERCP for stent removal in patients with biliary leak
14
. 
 
In our study, more than 90% of patients with choledocholithiasis, benign 
stricture, malignant stricture and bile leak with stricture or stone required repeat 
ERCP. However, in patients with simple bile leak, only 16 % needed intervention 
requiring ERCP; of those requiring subsequent therapy, four of them required 
sludge removal and the initial ERCP procedure notes failed to mention if there 
was any sludge or stone extracted, and in the 5
th  
case, stent removal was likely 
 
performed too soon; the low complication rate in those with simple bile leak 
suggests that stent removal using EGD may be a viable and cost-effective 
alternative for these patients. 
 
Our study has several limitations. Findings are based on retrospective 
data, and miscategorization remains possible. Relative to other groups, sample 
size in the bile leak group was relatively small, and thus our findings, while 
consistent with previous research, must be interpreted with caution. While we 
collected data on a large number of patients undergoing stent placement and 
removal using ERCP, we lacked information on outcomes of stent removal using 
EGD. Clearly, a larger, prospective study is needed to determine if EGD might be 
a cost effective substitute for ERCP in uncomplicated bile leak patients, and 
possibly other patient groups.   Studies are also needed to identify specific high 
18  
 
 
 
 
 
 
 
 
risk patient populations most likely to need follow-up interventions requiring 
ERCP in Bile leak group. Our findings strongly suggest that bile leak patients 
with sludge, microlithiasis or stricture during initial ERCP procedure will require 
follow up ERCP procedure to assess adequate resolution of associated pathology 
along with primary pathology. In these patients, complete extraction of the bile 
sludge during initial procedure would be beneficial, but would likely still not 
preclude using ERCP for stent removal. 
 
CONCLUSION 
 
 
In this retrospective chart review study of 284 patients undergoing stent 
removal, our findings suggest a repeat ERCP for stent removal will be required 
for over 90% of patients with a diagnosis of choledocholithiasis, benign stricture, 
malignant stricture and complicated bile leak. However, the low complication 
rates observed in patients with uncomplicated bile leak suggest that, for these 
patients, a regular side viewing EGD may provide a safer and more cost effective 
alternative to ERCP. Larger prospective studies should be conducted to clearly 
identify the risk factors that indicate the need for ERCP vs a regular EGD in 
patients with bile leak and possibly other conditions. 
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